The scientist, Dr. Fiona Havers, told colleagues at the Centers for Disease Control and Prevention on Monday that she no longer had confidence that the COVID and RSV data would be used "objectively or evaluated with appropriate scientific rigor to make evidence-based vaccine policy decisions," according to an email seen by Reuters.

A newly posted agenda for next week’s meeting of the just-appointed group of outside vaccine advisers to the US Centers for Disease Control and Prevention includes a discussion and vote on thimerosal in flu vaccines,